Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/129964
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFlórez Borges, Paloma-
dc.contributor.authorPérez Lozano, Pilar-
dc.contributor.authorGarcía Montoya, Encarna-
dc.contributor.authorMiñarro Carmona, Montserrat-
dc.contributor.authorJo, Enric-
dc.contributor.authorManich Bou, Albert-
dc.contributor.authorSuñé i Negre, Josep M. (Josep Maria)-
dc.date.accessioned2019-03-08T13:17:14Z-
dc.date.available2019-03-08T13:17:14Z-
dc.date.issued2018-04-24-
dc.identifier.issn1932-6203-
dc.identifier.urihttp://hdl.handle.net/2445/129964-
dc.description.abstractA preformulation study of an oral lyophilisate with cetirizine dihydrochloride (CTZ) as active ingredient, mannitol and PVP K30 as bulking agents is presented. CTZ shown a humidity content of 0.150% and a spontaneous hygroscopicity of 0.200% (both determined by SeDeM diagram), demonstrating an adequate stability behavior in solid form. A design of experiments (DoE) performed with both mannitol and PVP K30, followed by a simple factorial design (32) has determined the optimum combination of excipients and CTZ, and showed that a higher proportion of PVP K30 was able to prevent metastable forms generated by mannitol.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherPublic Library of Science (PLoS)-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0196049-
dc.relation.ispartofPLoS One, 2018, vol. 13, num. 4, p. e0196049-
dc.relation.urihttps://doi.org/10.1371/journal.pone.0196049-
dc.rightscc-by (c) Flórez Borges, Paloma et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationAdministració de medicaments-
dc.subject.classificationMedicació oral-
dc.subject.classificationMedicaments-
dc.subject.classificationDisseny de medicaments-
dc.subject.otherAdministration of drugs-
dc.subject.otherOral medication-
dc.subject.otherDrugs-
dc.subject.otherDrug design-
dc.titleThe Role of SeDeM Characterizing the Active Substance and Polyvynilpyrrolidone Eliminating Metastable Forms in an Oral Lyophilizate - A Preformulation Study.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec681312-
dc.date.updated2019-03-08T13:17:15Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29689061-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
681312.pdf1.11 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons